TL1A-Bindende Moleküle, Il-23P19-Bindende Moleküle und Bispezifische Antigenbindende Moleküle und Verwendungen davon
EP4786491
5. August 2026
Anmelder: Newsoara Biopharmaceutical Technology (Suzhou) Co., Ltd. 🇨🇳
Details
- Veröffentlichungs-Nr.
- EP4786491
- Anmeldetag
- 8. Januar 2026
- Veröffentlichung
- 5. August 2026
- Rechtsraum
- EP
Abstract
The present disclosure relates to TL1A-binding molecules, IL-23p19-binding molecules, and bispecific antigen-binding molecules that simultaneously target TL1A and IL-23p19. The disclosure also relates to nucleic acid molecules encoding said antigen-binding molecules, expression vectors, host cells, compositions thereof, and their use for treating diseases.
Anmelder
- Firma
- Newsoara Biopharmaceutical Technology (Suzhou) Co., Ltd.
- Land
- 🇨🇳 China